To confirm the contribution of PCNA to EIF3B-mediated cholangiocarcinoma progression, we established RBE cell models involving singular overexpression of EIF3B, singular silence of PCNA, and concurrent EIF3B overexpression with PCNA silencing. The gene discussed is EIF3B; the disease is cholangiocarcinoma.